HANGZHOU TIGERMED CO. H 1 Cash Flow Quality Index
HANGZHOU TIGERMED CO. H 1 cash flow quality index. HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Cash Flow Quality Index of 1.26x as of December 2025. Operating cash flow of €1.12 Billion exceeds net income of €887.89 Million, indicating high earnings quality where cash backs reported profits. See financial flexibility index of HANGZHOU TIGERMED CO. H 1 to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of HANGZHOU TIGERMED CO. H 1 (2021–2025)
Cash flow quality index of HANGZHOU TIGERMED CO. H 1 from 2021 to 2025. Historical Cash Flow Quality Index for HANGZHOU TIGERMED CO. H 1 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore HANGZHOU TIGERMED CO. H 1 cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
HANGZHOU TIGERMED CO. H 1 Cash Flow Quality Index by Year (2021–2025)
HANGZHOU TIGERMED CO. H 1 cash flow quality index by year from 2021 to 2025. Year-by-year earnings quality comparison for HANGZHOU TIGERMED CO. H 1. For the full cash flow conversion analysis, see cash efficiency ratio of HANGZHOU TIGERMED CO. H 1.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.26x | €1.12 Billion | €887.89 Million | ▼ -53.5% |
| 2024 | 2.71x | €1.10 Billion | €405.14 Million | ▲ +377.0% |
| 2023 | 0.57x | €1.15 Billion | €2.03 Billion | ▼ -15.7% |
| 2022 | 0.67x | €1.36 Billion | €2.02 Billion | ▲ +35.9% |
| 2021 | 0.50x | €1.42 Billion | €2.87 Billion | — |